Bio Roundup: Trump’s Triumph, Election Fallout, CRISPR Arguments & More
Xconomy
NOVEMBER 11, 2016
—Xconomy rounded up some post-election thoughts from several local tech and life science leaders , which included a mix of outrage, resiliency, hope, rationalizing, grandstanding, and some calls for calm and reason. Patent and Trademark Office. —Despite the patent fight, CRISPR work continues apace. 6 at the U.S.
87 
Let's personalize your content